IFLR is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 25,229 results that match your search.25,229 results
  • Allan Leung has replaced Roddy McKean as managing partner of Lovells' Hong Kong office. McKean has returned to the London office, where a group of key partners are plotting to cool Lovells' global expansion.
  • Linklaters and Clifford Chance are advising on the $1.3 billion restructuring of Malaysia's TRI and Celcom, the country's largest cellular phone operator. Linklaters is advising Celcom, the fully-owned operating subsidiary of TRI.
  • Korea's securitization market will be one to watch during 2001. Brown & Wood's Hong Kong office recently advised Chase Securities on the arrangement of a novel asset-backed securities issue for Asiana Airlines.
  • "We looked at a lot of different people—bigger, smaller—but this is like Goldilocks: the porridge is just right."
  • Orrick, Herrington & Sutcliffe and Clifford Chance have acted on a landmark UK asset-backed transaction, completing a £434 million ($641 million) securitization of the government's military aircraft leasing payments. The deal is believed to be the first securitization of military equipment in the UK, and one of the first aircraft securitizations to be governed by English law.
  • This month, IFLR presents extracts from the second and final part of the roundtable discussion on the unique issues faced by a company launching a cross-border internet offering
  • IFLR is proud to announce the nominations for its 2000 Awards. The winners will be revealed during a ceremony held at The Park Lane Hotel, London, on March 15 2001. For enquiries regarding the awards dinner and reservations please contact Nichola Whitaker on +44 (0) 20 7779 8467
  • Kazakhstan adopts stamp duty on notes and bills of exchangeBaker & McKenzie
  • New rules for listing on the SWX local capsWenger Vieli Belser
  • Paul Geradine, the FSA's director of listing The UK Financial Services Authority (FSA) has endured a stern test of its disclosure policies for biotechnology companies, after controversial UK group Huntingdon Life Sciences avoided closure by securing a last-minute investment package. In a press release on January 17 the FSA announced a new system designed to encourage more biotech companies to list in the UK.